<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03045367</url>
  </required_header>
  <id_info>
    <org_study_id>CS/526</org_study_id>
    <nct_id>NCT03045367</nct_id>
  </id_info>
  <brief_title>Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery</brief_title>
  <official_title>Mid-term Clinical Assessment and Correlation Between Metamorphopsia, Visual Acuity and Foveal Thickness in Idiopathic Epiretinal Membrane and Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Oculistica dell'Università di Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinica Oculistica dell'Università di Torino</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge
      vitrectomy and phacoemulsification with intraocular lens implant in patients with
      metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All
      30 patients recruited underwent complete ocular examination, visual acuity measurement with
      ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness
      evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 22, 2015</start_date>
  <completion_date type="Actual">October 31, 2016</completion_date>
  <primary_completion_date type="Actual">October 31, 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>180 Days</target_duration>
  <primary_outcome>
    <measure>Metamorphopsia</measure>
    <time_frame>Change in metamorphopsia from baseline at 180 days.</time_frame>
    <description>Change in spatial degree of distortion perception</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Change in visual acuity from baseline at 180 days</time_frame>
    <description>Change in LogMAR visual acuity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area of central scotoma</measure>
    <time_frame>Change in area of central scotoma from baseline at 180 days</time_frame>
    <description>Change in area, in square pixel, of central scotoma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Central fovea thickness</measure>
    <time_frame>Change in fovea thickness from baseline at 180 days</time_frame>
    <description>Change in fovea thickness in µm at the Sd OCT</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Epiretinal Membrane</condition>
  <condition>Cataract Senile</condition>
  <arm_group>
    <arm_group_label>Outpatients</arm_group_label>
    <description>Phacoemulsification, intraocular lens implant, vitrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Phacoemulsification, intraocular lens implant, vitrectomy.</intervention_name>
    <description>Cataract extraction, intraocular lens implant, vitrectomy, epiretinal membrane and inner limiting retinal membrane peeling.</description>
    <arm_group_label>Outpatients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatient of all gender, with complain of visual impairment and distortion
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 55 years

          -  visual acuity ≤ 20/40

          -  idiopathic epiretinal membrane

          -  cataract

          -  Amsler test positive for metamorphopsia.

        Exclusion Criteria:

          -  previous ocular interventions

          -  other ocular diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2017</study_first_submitted>
  <study_first_submitted_qc>February 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>February 3, 2017</last_update_submitted>
  <last_update_submitted_qc>February 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinica Oculistica dell'Università di Torino</investigator_affiliation>
    <investigator_full_name>Marco DAL VECCHIO, MD</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Metamorphopsia</keyword>
  <keyword>Epiretinal membrane</keyword>
  <keyword>Vitrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Epiretinal Membrane</mesh_term>
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

